Participants 24 162 3
encephalopathic syndromes and risk factors for their occurrence and outcome during melarsoprol treatment of human African trypanosomiasis.
Participants 264 545 6
To investigate the existence of risk factors, the incidence of encephalopathic syndromes and the relationship between the development of different types of encephalopathies and the clinical outcome was studied in a clinical trial with 588 patients under treatment with melarsoprol.
Participants 550 701 4
38 encephalopathy cases were classified into three types according to the leading clinical picture: coma type, convulsion type and psychotic reactions.
